Xuli Meng
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 3
- Oncology 13
- Cancer Cells and Metastasis 5
- Co-authors
- Qinghui Zheng (20 shared papers)Fangfang Zhou (7 shared papers)Long Zhang (6 shared papers)Heyu Li (3 shared papers)Hongchao Tang (16 shared papers)Bin Wang (1 shared paper)Mengdi Zhang (1 shared paper)Jie Qiu (1 shared paper)
- Journals
- Frontiers in Immunology (4 papers)Advanced Science (3 papers)Frontiers in Oncology (3 papers)European Journal of Medicinal Chemistry (2 papers)World Journal of Surgical Oncology (2 papers)
- Partner nations
- ChinaGermanyNetherlands
In The Last Decade
Xuli Meng
49 papers receiving 1.1k citations
Xuli Meng's Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 239
- Oncology 239
- Molecular Biology 587
- Immunology 148
- Cell Biology 98
Countries citing papers authored by Xuli Meng
This map shows the geographic impact of Xuli Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuli Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuli Meng more than expected).
Fields of papers citing papers by Xuli Meng
This network shows the impact of papers produced by Xuli Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuli Meng. The network helps show where Xuli Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuli Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy Hit paper breakdown → | 2023 | 165 |
| 2 | 2022 | 121 | |
| 3 | 2020 | 114 | |
| 4 | 2021 | 91 | |
| 5 | 2022 | 65 | |
| 6 | 2021 | 50 | |
| 7 | 2023 | 47 | |
| 8 | 2022 | 43 | |
| 9 | 2022 | 40 | |
| 10 | Targeting FOXM1 condensates reduces breast tumour growth and metastasis Hit paper breakdown → | 2025 | 36 |
| 11 | 2019 | 35 | |
| 12 | 2023 | 34 | |
| 13 | 2024 | 29 | |
| 14 | 2023 | 28 | |
| 15 | 2017 | 18 | |
| 16 | 2022 | 17 | |
| 17 | 2023 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2021 | 14 | |
| 20 | 2015 | 14 |
About Xuli Meng
Xuli Meng is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Breast Cancer Treatment Studies (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Genomics and Diagnostics (3 papers), Immune cells in cancer (3 papers), RNA modifications and cancer (3 papers), FOXO transcription factor regulation (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (239 citations), Oncology (239 citations), Molecular Biology (587 citations), Immunology (148 citations) and Cell Biology (98 citations). Xuli Meng has collaborated with scholars based in China, Germany and Netherlands. Frequent co-authors include Qinghui Zheng, Fangfang Zhou, Long Zhang, Heyu Li, Hongchao Tang, Bin Wang, Mengdi Zhang, Jie Qiu, Feng Chu and Li Ling. Their work appears in journals such as Frontiers in Immunology, Advanced Science, Frontiers in Oncology, European Journal of Medicinal Chemistry and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.